Group One Trading »

Karyopharm Therapeutics shares owned by Group One Trading

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Group One Trading from 13F filings

Historical chart of Group One Trading investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Group One Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Group One Trading

Quarter filed Position value Share count Share price at filing
2025-09-30 $448k 68k 6.54
2025-06-30 $422k 98k 4.31

More positions owned by Group One Trading

Tesla Motors Inc cmn Call Option
Unitedhealth Group Inc option Call Option
Meta Platforms Cl A Call Option
Alibaba Group Hldg Sponsored Ads Call Option
Strategy Cl A New Put Option
Strategy Cl A New Call Option
Nvidia Corp option Call Option
Meta Platforms Cl A Put Option
Microsoft Corp Call Option
Robinhood Mkts Com Cl A Call Option
Apple Inc option Call Option
Tesla Motors Inc cmn Put Option
Lilly Eli & Co option Call Option
Iren Ordinary Shares Put Option
Iren Ordinary Shares Call Option

View all positions for Group One Trading

Top funds holding Karyopharm Therapeutics

T. Rowe Price Investment Management
Adage Capital Partners GP
Vanguard Group
Susquehanna International
BlackRock
Affinity Asset Advisors
Catalio Capital Management
Avidity Partners Management
Marshall Wace
CAM Group Holding A/S
Geode Capital Management
Citadel Advisors
Group One Trading
Renaissance Technologies
UBS Group

View all funds holding Karyopharm Therapeutics